Bile acids, key compounds for the mechanistic analyses of hepatotoxicity, and nuclear receptor interaction

胆汁酸,肝毒性机制分析和核受体相互作用的关键化合物

基本信息

  • 批准号:
    15390043
  • 负责人:
  • 金额:
    $ 9.79万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

Supplement of 1% lithocholic acid (LCA) in the diet for 5-9 days resulted in elevated levels of the marker for liver damage aspartate aminotransferase (AST) and alkaline phosphatase (ALP) activities in both FXR-null and wild-type female mice. The levels were clearly higher in wild-type mice than in FXR-null mice. Consistent with liver toxicity marker activities, serum and liver levels of bile acids, particularly LCA and tauroLCA, were clearly higher in wild-type mice than in FXR-null mice after 1% LCA supplement. Marked increases in hepatic sulfating activity for LCA (5.5-fold) and hydroxysteroid sulfotransferase St2a (5.8-fold) were detected in liver of FXR-null mice. A 7.4-fold higher 3a-sulfated bile acid concentration was observed in gallbladder bile of FXR-null mice fed a LCA diet compared to that of wild-type mice. These results indicate that LCA sulfation catalyzed by hydroxysteroid sulfotransferase is at least one pathway for protection against LCA-induced liver damage. Further … More more, northern blot analysis using FXR-null, PXR-null and FXR-PXR double-null mice suggests a repressive role of these nuclear receptors on basal St2a expression.FXR-null mice are highly sensitive to cholic acid (CA)-induced liver toxicity. AST activity was elevated 15.7-fold after feeding a 0.25% CA diet, whereas only slight increases in serum AST (1.7-fold and 2.5-fold) were observed in wild-type mice fed 0.25% and 1% CA diet, respectively. The bile acid output rate was 2.0-fold and 3.7-fold higher after feeding of 0.25 and 1.0% CA diet in wild-type mice, respectively. On the other hand, no significant increase in bile acid output rate was observed in FXR-null mice fed 0.25% CA diet in contrast to a significant decrease observed in mice fed a 1.0% CA diet in spite of the markedly higher levels of hepatic tauro-conjugated bile acids. These results suggest that the CA-induced enhancement of canalicular bile acid output rate is involved in adaptive responses for prevention of CA-induced toxicity. Less
在饲料中添加1%石胆酸(LCA)5-9天后,FXR基因缺失和野生型雌性小鼠肝损伤标志物天冬氨酸氨基转移酶(AST)和碱性磷酸酶(ALP)活性均升高。野生型小鼠的这一水平明显高于FXR基因缺失小鼠。与肝脏毒性标记物活性一致,补充1%LCA后,野生型小鼠的血清和肝脏胆汁酸水平,特别是LCA和tauroLCA,明显高于FXR缺陷型小鼠。在FXR基因缺失小鼠的肝脏中,LCA的硫酸盐化活性(5.5倍)和羟基类固醇磺基转移酶St2a(5.8倍)显著增加。与野生型小鼠相比,饲喂LCA饮食的FXR基因缺失小鼠的胆汁中3a-硫酸盐胆汁酸浓度增加了7.4倍。这些结果表明,羟基类固醇磺基转移酶催化的LCA硫化至少是保护LCA所致肝损伤的一条途径。进一步的…此外,对FXR缺失、PXR缺失和FXR-PXR双缺失小鼠的Northern印迹分析表明,这些核受体对基础St2a的表达具有抑制作用。FXR缺失小鼠对胆酸(CA)诱导的肝脏毒性高度敏感。饲喂0.25%CA饲料后,AST活性提高15.7倍,而饲喂0.25%和1%CA饲料的野生型小鼠血清AST仅轻微升高(1.7倍和2.5倍)。野生型小鼠饲喂0.25%和1.0%CA饲料后,胆汁酸产生率分别提高2.0倍和3.7倍。另一方面,尽管肝脏牛磺酸结合胆汁酸水平显著升高,但饲喂0.25%CA饲料的FXR基因缺失小鼠的胆汁酸产量没有显著增加,而饲喂1.0%CA饲料的小鼠的胆汁酸产量显著降低。这些结果表明,CA诱导的小管胆汁酸产量的增加参与了预防CA毒性的适应性反应。较少

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
M.Miyata: "Thalidomide-induced suppression of embryo fibroblast proliferation requires CYP1A1-mediated activation"Drug Metab.Dispos.. 31. 469-475 (2003)
M.Miyata:“沙利度胺诱导的胚胎成纤维细胞增殖抑制需要 CYP1A1 介导的激活”Drug Metab.Dispos.. 31. 469-475 (2003)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Regulation of drug transporter by femesoid X receptor in mice
femesoid X 受体对小鼠药物转运蛋白的调节
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Masaki Fujieda et al.;Suzuki et al.;T.Maeda
  • 通讯作者:
    T.Maeda
Regulation of drug transporter by fernesoid X receptor in mice.
小鼠体内 Fernesoid X 受体对药物转运蛋白的调节。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    T.Maeda;M.Miyata;T.Yotsumoto;D.Kobayashi;T.Nozawa;K.Toyama;F.J.Gonzalez;Y.Yamazoe;I.Tamai
  • 通讯作者:
    I.Tamai
M.Miyata: "Grapefruit juice intake does not enhance but rather protects against aflatoxin B1-induced liver DNA damage through a reduction in hepatic CYP3A activity"Carcinogenesis. 25. 203-209 (2003)
M.Miyata:“摄入葡萄柚汁不会增强而是通过降低肝脏 CYP3A 活性来防止黄曲霉毒素 B1 诱导的肝脏 DNA 损伤”致癌作用。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMAZOE Yasushi其他文献

YAMAZOE Yasushi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMAZOE Yasushi', 18)}}的其他基金

CYP3A4 induction-associated dyslipidemia : a new risk factor for lifestyle disease
CYP3A4诱导相关的血脂异常:生活方式病的新危险因素
  • 批准号:
    22659028
  • 财政年份:
    2010
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Regulation of hepatic lipid metabolism through ileal bile acid-FGF signaling
通过回肠胆汁酸-FGF信号调节肝脏脂质代谢
  • 批准号:
    21390039
  • 财政年份:
    2009
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanisms for delayed organ toxicity induced by drug and prediction system using comprehensive analysis
药物迟发性器官毒性机制及综合分析预测系统
  • 批准号:
    19390037
  • 财政年份:
    2007
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanism for human-specific hepatotoxicity and development of prediction system
人类特异性肝毒性机制及预测系统开发
  • 批准号:
    17390039
  • 财政年份:
    2005
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Human characteristic mechanism of enzyme induction and the prediction
人体特有的酶诱导机制及预测
  • 批准号:
    13470510
  • 财政年份:
    2001
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Grapefruit juice-drug interaction and the prediction
葡萄柚汁与药物的相互作用及预测
  • 批准号:
    12557225
  • 财政年份:
    2000
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of intestinal oxidative metabolism on first pass effect
肠道氧化代谢对首过效应的作用
  • 批准号:
    09470496
  • 财政年份:
    1997
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of as table expression system for human drug metabolizing enzymes
人药物代谢酶as表表达系统的开发
  • 批准号:
    07557149
  • 财政年份:
    1995
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analysis of mechanism of neonatal imprinting of drug-metabolizing enzymes of rat liver
大鼠肝脏药物代谢酶新生期印记机制分析
  • 批准号:
    60480130
  • 财政年份:
    1985
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Nuclear receptor regulation of a breast cancer stem cell population
乳腺癌干细胞群的核受体调节
  • 批准号:
    9516953
  • 财政年份:
    2016
  • 资助金额:
    $ 9.79万
  • 项目类别:
NUCLEAR RECEPTOR REGULATION OF THE C ELEGANS DETOXIFICATION NETWORK
线虫解毒网络的核受体调节
  • 批准号:
    7959441
  • 财政年份:
    2009
  • 资助金额:
    $ 9.79万
  • 项目类别:
Role of a Novel Corepressor in Nuclear Receptor Action
新型辅阻遏物在核受体作用中的作用
  • 批准号:
    7100498
  • 财政年份:
    2006
  • 资助金额:
    $ 9.79万
  • 项目类别:
Nuclear receptor coactivator PGC-1a in DNA damage
DNA损伤中的核受体共激活剂PGC-1a
  • 批准号:
    7019236
  • 财政年份:
    2005
  • 资助金额:
    $ 9.79万
  • 项目类别:
Nuclear receptor coactivator PGC-1a in DNA damage
DNA损伤中的核受体共激活剂PGC-1a
  • 批准号:
    7140633
  • 财政年份:
    2005
  • 资助金额:
    $ 9.79万
  • 项目类别:
Regulation Code by Nuclear Receptor Coactivator ASC-2
核受体共激活剂 ASC-2 的调节代码
  • 批准号:
    6777364
  • 财政年份:
    2004
  • 资助金额:
    $ 9.79万
  • 项目类别:
Regulation Code by Nuclear Receptor Coactivator ASC-2
核受体共激活剂 ASC-2 的调节代码
  • 批准号:
    7024422
  • 财政年份:
    2004
  • 资助金额:
    $ 9.79万
  • 项目类别:
Nuclear Receptor Regulation of Detoxification Networks
解毒网络的核受体调节
  • 批准号:
    6805375
  • 财政年份:
    2004
  • 资助金额:
    $ 9.79万
  • 项目类别:
Regulation Code by Nuclear Receptor Coactivator ASC-2
核受体共激活剂 ASC-2 的调节代码
  • 批准号:
    6850823
  • 财政年份:
    2004
  • 资助金额:
    $ 9.79万
  • 项目类别:
Orphan Nuclear Receptor COUP TFI in Hearing and Balance
孤儿核受体 COUP TFI 在听力和平衡方面的作用
  • 批准号:
    6516266
  • 财政年份:
    2001
  • 资助金额:
    $ 9.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了